MINNEAPOLIS, Aug 12, 2010 (BUSINESS WIRE) --

Medtronic, Inc. (NYSE: MDT) today announced it has completed its acquisition of ATS Medical, Inc. following payment of $4.00 per share in cash for each share of ATS Medical stock and assumption of net debt, with a total transaction value of approximately $370 million.

"Medtronic is focused on providing innovative solutions for cardiac surgeons and their patients worldwide," said John Liddicoat, M.D., vice president and general manager of the Structural Heart business at Medtronic. "Our completed purchase of ATS Medical immediately expands Medtronic's product offerings and pipeline of surgical valves, repair products and surgical ablation technologies."

Medtronic is committed to advancing the treatment of structural heart disease through collaboration with leading clinicians, researchers and scientists worldwide.

About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

SOURCE: Medtronic, Inc.

Medtronic, Inc.
Public Relations:
Christopher Garland, 763-526-1621
or
Investor Relations:
Jeff Warren, 763-505-2696